Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Breast Neoplasms 30Rectal Neoplasms 21Esophageal Neoplasms 15Colorectal Neoplasms 15Pancreatic Neoplasms 12Lung Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Prostatic Neoplasms 10Adenocarcinoma Of Esophagus 9Stomach Neoplasms 8Squamous Cell Carcinoma of Head and Neck 8Ovarian Neoplasms 8Head and Neck Neoplasms 8Sarcoma 7Esophageal Squamous Cell Carcinoma 7Neoplasms 5Colonic Neoplasms 5Central Nervous System Neoplasms 5Carcinoma, Intraductal, Noninfiltrating 5Urinary Bladder Neoplasms 4Inflammatory Breast Neoplasms 4Fallopian Tube Neoplasms 4Breast Neoplasms, Male 4Breast Carcinoma In Situ 4Brain Neoplasms 4Recurrence 3Neoplasm Metastasis 3Kidney Neoplasms 3Glioma 3Glioblastoma 3

Interventions

Imatinib Mesylate 41Sunitinib 17nilotinib 12regorafenib 10ripretinib 6avapritinib 6Leucovorin 3Ipilimumab 3Gemcitabine 3Dasatinib 3CTLA-4 Antigen 34-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 3pexidartinib 2Paclitaxel 2Oxaliplatin 2Midazolam 2Irinotecan 2Fluorouracil 2Floxuridine 2Erlotinib Hydrochloride 2Docetaxel 2Cisplatin 2Carboplatin 2Capecitabine 2Biopsy, Fine-Needle 2Bevacizumab 2vatalanib 1umbralisib 1trametinib 1tinostamustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Gastrointestinal Stromal Tumors × Neoadjuvant Therapy × Clear all
NCT00112632 2012-03-08

Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor

Technical University of Munich

Phase 2 Completed
40 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡